GO:0008017 | microtubule binding | 6.09% (12/197) | 4.32 | 0.0 | 0.0 |
GO:0015631 | tubulin binding | 6.09% (12/197) | 4.15 | 0.0 | 0.0 |
GO:0005488 | binding | 54.82% (108/197) | 0.8 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 14.21% (28/197) | 2.15 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 15.74% (31/197) | 1.97 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 7.61% (15/197) | 3.08 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 17.77% (35/197) | 1.71 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 15.74% (31/197) | 1.83 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 15.74% (31/197) | 1.8 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 4.06% (8/197) | 4.61 | 0.0 | 0.0 |
GO:0007018 | microtubule-based movement | 4.06% (8/197) | 4.61 | 0.0 | 0.0 |
GO:0008092 | cytoskeletal protein binding | 6.09% (12/197) | 3.41 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 15.74% (31/197) | 1.77 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 27.92% (55/197) | 1.19 | 0.0 | 0.0 |
GO:0003774 | cytoskeletal motor activity | 4.06% (8/197) | 4.32 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 29.44% (58/197) | 1.1 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 34.52% (68/197) | 0.96 | 0.0 | 1e-06 |
GO:0009987 | cellular process | 37.06% (73/197) | 0.9 | 0.0 | 1e-06 |
GO:0003674 | molecular_function | 68.02% (134/197) | 0.49 | 0.0 | 1e-06 |
GO:0008150 | biological_process | 51.78% (102/197) | 0.66 | 0.0 | 1e-06 |
GO:0140657 | ATP-dependent activity | 8.12% (16/197) | 2.48 | 0.0 | 1e-06 |
GO:0007017 | microtubule-based process | 4.57% (9/197) | 3.66 | 0.0 | 2e-06 |
GO:0005524 | ATP binding | 17.77% (35/197) | 1.45 | 0.0 | 2e-06 |
GO:0003676 | nucleic acid binding | 19.29% (38/197) | 1.32 | 0.0 | 4e-06 |
GO:0005515 | protein binding | 25.38% (50/197) | 1.07 | 0.0 | 7e-06 |
GO:0044238 | primary metabolic process | 30.96% (61/197) | 0.92 | 0.0 | 7e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.77% (35/197) | 1.32 | 0.0 | 1.4e-05 |
GO:0022402 | cell cycle process | 3.55% (7/197) | 3.74 | 1e-06 | 2.6e-05 |
GO:0032559 | adenyl ribonucleotide binding | 17.77% (35/197) | 1.25 | 1e-06 | 3.6e-05 |
GO:0003723 | RNA binding | 8.63% (17/197) | 1.94 | 3e-06 | 6.4e-05 |
GO:0006396 | RNA processing | 6.09% (12/197) | 2.44 | 3e-06 | 6.6e-05 |
GO:0071704 | organic substance metabolic process | 30.96% (61/197) | 0.81 | 4e-06 | 8.9e-05 |
GO:0032553 | ribonucleotide binding | 18.27% (36/197) | 1.16 | 4e-06 | 9.3e-05 |
GO:0044237 | cellular metabolic process | 24.87% (49/197) | 0.94 | 4e-06 | 9.5e-05 |
GO:0030554 | adenyl nucleotide binding | 17.77% (35/197) | 1.18 | 4e-06 | 9.5e-05 |
GO:0097367 | carbohydrate derivative binding | 18.27% (36/197) | 1.14 | 5e-06 | 0.000112 |
GO:0140097 | catalytic activity, acting on DNA | 4.06% (8/197) | 3.05 | 6e-06 | 0.000127 |
GO:0032991 | protein-containing complex | 10.66% (21/197) | 1.6 | 7e-06 | 0.000137 |
GO:0032555 | purine ribonucleotide binding | 17.77% (35/197) | 1.14 | 8e-06 | 0.000158 |
GO:1903047 | mitotic cell cycle process | 2.03% (4/197) | 4.9 | 9e-06 | 0.000167 |
GO:0008152 | metabolic process | 31.98% (63/197) | 0.75 | 9e-06 | 0.000172 |
GO:0043168 | anion binding | 18.78% (37/197) | 1.05 | 1.6e-05 | 0.000278 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 6.6% (13/197) | 2.07 | 1.6e-05 | 0.000284 |
GO:0140513 | nuclear protein-containing complex | 4.57% (9/197) | 2.61 | 1.9e-05 | 0.000321 |
GO:0006281 | DNA repair | 4.06% (8/197) | 2.79 | 2.4e-05 | 0.000387 |
GO:0017076 | purine nucleotide binding | 17.77% (35/197) | 1.06 | 2.4e-05 | 0.000395 |
GO:1901265 | nucleoside phosphate binding | 18.27% (36/197) | 1.03 | 3.1e-05 | 0.000465 |
GO:0000166 | nucleotide binding | 18.27% (36/197) | 1.03 | 3.1e-05 | 0.000465 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.05% (6/197) | 3.35 | 2.9e-05 | 0.000466 |
GO:1901363 | heterocyclic compound binding | 18.78% (37/197) | 1.01 | 3e-05 | 0.00047 |
GO:0006974 | DNA damage response | 4.06% (8/197) | 2.71 | 3.4e-05 | 0.000502 |
GO:0036094 | small molecule binding | 18.78% (37/197) | 1.0 | 3.6e-05 | 0.000517 |
GO:0010564 | regulation of cell cycle process | 2.03% (4/197) | 4.36 | 4.2e-05 | 0.000592 |
GO:0000398 | mRNA splicing, via spliceosome | 2.54% (5/197) | 3.52 | 7.9e-05 | 0.001084 |
GO:0006260 | DNA replication | 2.54% (5/197) | 3.52 | 7.9e-05 | 0.001084 |
GO:0033554 | cellular response to stress | 4.06% (8/197) | 2.52 | 8.5e-05 | 0.001143 |
GO:0051716 | cellular response to stimulus | 4.06% (8/197) | 2.46 | 0.000114 | 0.00151 |
GO:0005575 | cellular_component | 19.29% (38/197) | 0.9 | 0.000116 | 0.001514 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.54% (5/197) | 3.35 | 0.000138 | 0.001771 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.54% (5/197) | 3.28 | 0.000174 | 0.002186 |
GO:0034470 | ncRNA processing | 3.05% (6/197) | 2.84 | 0.000205 | 0.002543 |
GO:0034660 | ncRNA metabolic process | 3.55% (7/197) | 2.55 | 0.000213 | 0.002589 |
GO:0016070 | RNA metabolic process | 7.11% (14/197) | 1.61 | 0.000233 | 0.002793 |
GO:0051128 | regulation of cellular component organization | 2.03% (4/197) | 3.69 | 0.000264 | 0.003111 |
GO:0008380 | RNA splicing | 2.54% (5/197) | 3.1 | 0.000307 | 0.003563 |
GO:0051726 | regulation of cell cycle | 2.03% (4/197) | 3.56 | 0.000379 | 0.00433 |
GO:0043229 | intracellular organelle | 7.61% (15/197) | 1.43 | 0.000506 | 0.00562 |
GO:0043226 | organelle | 7.61% (15/197) | 1.43 | 0.000506 | 0.00562 |
GO:0032147 | activation of protein kinase activity | 1.02% (2/197) | 5.78 | 0.000542 | 0.00576 |
GO:0005819 | spindle | 1.02% (2/197) | 5.78 | 0.000542 | 0.00576 |
GO:0043167 | ion binding | 22.84% (45/197) | 0.71 | 0.000529 | 0.00579 |
GO:0099513 | polymeric cytoskeletal fiber | 1.52% (3/197) | 4.14 | 0.000646 | 0.006504 |
GO:0099512 | supramolecular fiber | 1.52% (3/197) | 4.14 | 0.000646 | 0.006504 |
GO:0005874 | microtubule | 1.52% (3/197) | 4.14 | 0.000646 | 0.006504 |
GO:0099081 | supramolecular polymer | 1.52% (3/197) | 4.14 | 0.000646 | 0.006504 |
GO:0090224 | regulation of spindle organization | 1.02% (2/197) | 5.56 | 0.000755 | 0.007406 |
GO:0060236 | regulation of mitotic spindle organization | 1.02% (2/197) | 5.56 | 0.000755 | 0.007406 |
GO:0051276 | chromosome organization | 2.03% (4/197) | 3.28 | 0.000793 | 0.007677 |
GO:0043228 | non-membrane-bounded organelle | 4.57% (9/197) | 1.87 | 0.000881 | 0.008316 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4.57% (9/197) | 1.87 | 0.000881 | 0.008316 |
GO:0016043 | cellular component organization | 5.58% (11/197) | 1.64 | 0.000897 | 0.008358 |
GO:0033043 | regulation of organelle organization | 1.52% (3/197) | 3.95 | 0.000961 | 0.008637 |
GO:0099080 | supramolecular complex | 1.52% (3/197) | 3.95 | 0.000961 | 0.008637 |
GO:1990904 | ribonucleoprotein complex | 3.05% (6/197) | 2.42 | 0.000944 | 0.008688 |
GO:0045860 | positive regulation of protein kinase activity | 1.02% (2/197) | 5.36 | 0.001003 | 0.008806 |
GO:0001934 | positive regulation of protein phosphorylation | 1.02% (2/197) | 5.36 | 0.001003 | 0.008806 |
GO:0010562 | positive regulation of phosphorus metabolic process | 1.02% (2/197) | 5.19 | 0.001284 | 0.010541 |
GO:0045937 | positive regulation of phosphate metabolic process | 1.02% (2/197) | 5.19 | 0.001284 | 0.010541 |
GO:0033674 | positive regulation of kinase activity | 1.02% (2/197) | 5.19 | 0.001284 | 0.010541 |
GO:0003918 | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 1.02% (2/197) | 5.19 | 0.001284 | 0.010541 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.02% (2/197) | 5.19 | 0.001284 | 0.010541 |
GO:0042327 | positive regulation of phosphorylation | 1.02% (2/197) | 5.19 | 0.001284 | 0.010541 |
GO:0006397 | mRNA processing | 2.54% (5/197) | 2.63 | 0.001346 | 0.010931 |
GO:1990234 | transferase complex | 2.54% (5/197) | 2.59 | 0.001535 | 0.012328 |
GO:0032886 | regulation of microtubule-based process | 1.02% (2/197) | 4.9 | 0.001947 | 0.015471 |
GO:0071840 | cellular component organization or biogenesis | 5.58% (11/197) | 1.47 | 0.002283 | 0.017954 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 1.02% (2/197) | 4.78 | 0.002327 | 0.01811 |
GO:0007346 | regulation of mitotic cell cycle | 1.02% (2/197) | 4.66 | 0.002739 | 0.020887 |
GO:0006265 | DNA topological change | 1.02% (2/197) | 4.66 | 0.002739 | 0.020887 |
GO:0006996 | organelle organization | 3.05% (6/197) | 2.07 | 0.003305 | 0.024951 |
GO:0016071 | mRNA metabolic process | 2.54% (5/197) | 2.33 | 0.00335 | 0.025044 |
GO:0003916 | DNA topoisomerase activity | 1.02% (2/197) | 4.46 | 0.003657 | 0.027073 |
GO:1902494 | catalytic complex | 3.55% (7/197) | 1.82 | 0.003996 | 0.029293 |
GO:0005694 | chromosome | 1.02% (2/197) | 4.36 | 0.004163 | 0.029654 |
GO:0031401 | positive regulation of protein modification process | 1.02% (2/197) | 4.36 | 0.004163 | 0.029654 |
GO:0005732 | sno(s)RNA-containing ribonucleoprotein complex | 1.02% (2/197) | 4.36 | 0.004163 | 0.029654 |
GO:0016307 | obsolete phosphatidylinositol phosphate kinase activity | 1.02% (2/197) | 4.28 | 0.0047 | 0.032854 |
GO:0051347 | positive regulation of transferase activity | 1.02% (2/197) | 4.28 | 0.0047 | 0.032854 |
GO:0019538 | protein metabolic process | 14.21% (28/197) | 0.72 | 0.006106 | 0.034923 |
GO:1902407 | assembly of actomyosin apparatus involved in mitotic cytokinesis | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0097255 | R2TP complex | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0140719 | constitutive heterochromatin formation | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0030620 | U2 snRNA binding | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:1902410 | mitotic cytokinetic process | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0000914 | phragmoplast assembly | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0031509 | subtelomeric heterochromatin formation | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0032506 | cytokinetic process | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0033314 | mitotic DNA replication checkpoint signaling | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0043625 | delta DNA polymerase complex | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0010212 | response to ionizing radiation | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0045488 | pectin metabolic process | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0010393 | galacturonan metabolic process | 0.51% (1/197) | 7.36 | 0.006073 | 0.035 |
GO:0050794 | regulation of cellular process | 10.66% (21/197) | 0.88 | 0.005083 | 0.035205 |
GO:0051493 | regulation of cytoskeleton organization | 1.02% (2/197) | 4.19 | 0.005266 | 0.035819 |
GO:0030684 | preribosome | 1.02% (2/197) | 4.19 | 0.005266 | 0.035819 |
GO:1901564 | organonitrogen compound metabolic process | 16.75% (33/197) | 0.66 | 0.005363 | 0.036151 |
GO:0005643 | nuclear pore | 1.02% (2/197) | 4.04 | 0.006488 | 0.036554 |
GO:0006399 | tRNA metabolic process | 2.03% (4/197) | 2.44 | 0.006452 | 0.036624 |
GO:1901987 | regulation of cell cycle phase transition | 1.02% (2/197) | 4.12 | 0.005862 | 0.039168 |
GO:0051247 | positive regulation of protein metabolic process | 1.02% (2/197) | 3.97 | 0.007142 | 0.039943 |
GO:0008033 | tRNA processing | 1.52% (3/197) | 2.9 | 0.007623 | 0.042321 |
GO:0071103 | DNA conformation change | 1.02% (2/197) | 3.9 | 0.007825 | 0.043124 |
GO:0006284 | base-excision repair | 1.02% (2/197) | 3.84 | 0.008536 | 0.046703 |
GO:0006364 | rRNA processing | 1.52% (3/197) | 2.82 | 0.00896 | 0.048667 |